{"entity":{"type":"insider","cik":"0001825313","url":"/insider/0001825313","json_url":"/insider/0001825313.json","name":"Ikarian Healthcare Fund GP, L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":8,"n_filings":3,"first":"2020-09-17","last":"2020-12-30","span_basis":"filed_date"},"name_variants":[{"name":"Ikarian Healthcare Fund GP, L.P.","source":"filing","n_filings":3,"first_seen":"2020-09-17","last_seen":"2020-12-30"}],"transactions":[{"id":2954147,"accession":"0000899243-20-035537","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-035537","line_url":"/filing/0000899243-20-035537#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":null,"owner_name":"Ikarian Healthcare Fund GP, L.P.; Chart Westcott Living Trust; Ikarian Healthcare Master Fund, L.P.; Shahrestani Neil; Ikarian Capital, LLC","owner_display_name":"Ikarian Healthcare Fund GP, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":520291.0,"shares_display":"520,291","price_per_share":9.61,"price_display":"9.61","price_state":"stated","total_value":4999996.51,"total_display":"4,999,996.51","total_whole":"4,999,997","shares_owned_after":2716840.0,"shares_owned_after_display":"2,716,840","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-12-30","filed_date":"2020-12-30","scope":"insider"},{"id":2133521,"accession":"0000899243-20-030865","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-030865","line_url":"/filing/0000899243-20-030865#line-3","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":null,"owner_name":"Ikarian Healthcare Fund GP, L.P.; Ikarian Healthcare Master Fund, L.P.; Ikarian Capital, LLC; Chart Westcott Living Trust; Shahrestani Neil","owner_display_name":"Ikarian Healthcare Fund GP, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":7.5258,"price_display":"7.53","price_state":"stated","total_value":37629.0,"total_display":"37,629.00","total_whole":"37,629","shares_owned_after":2196549.0,"shares_owned_after_display":"2,196,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-11-11","filed_date":"2020-11-12","scope":"insider"},{"id":2133519,"accession":"0000899243-20-030865","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030865","line_url":"/filing/0000899243-20-030865#line-2","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":null,"owner_name":"Ikarian Healthcare Fund GP, L.P.; Ikarian Healthcare Master Fund, L.P.; Ikarian Capital, LLC; Chart Westcott Living Trust; Shahrestani Neil","owner_display_name":"Ikarian Healthcare Fund GP, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21300.0,"shares_display":"21,300","price_per_share":4.6435,"price_display":"4.64","price_state":"stated","total_value":98906.55,"total_display":"98,906.55","total_whole":"98,907","shares_owned_after":2191549.0,"shares_owned_after_display":"2,191,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-30","filed_date":"2020-11-12","scope":"insider"},{"id":2133517,"accession":"0000899243-20-030865","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-030865","line_url":"/filing/0000899243-20-030865#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":null,"owner_name":"Ikarian Healthcare Fund GP, L.P.; Ikarian Healthcare Master Fund, L.P.; Ikarian Capital, LLC; Chart Westcott Living Trust; Shahrestani Neil","owner_display_name":"Ikarian Healthcare Fund GP, L.P.","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7700.0,"shares_display":"7,700","price_per_share":4.7706,"price_display":"4.77","price_state":"stated","total_value":36733.62,"total_display":"36,733.62","total_whole":"36,734","shares_owned_after":2170249.0,"shares_owned_after_display":"2,170,249","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-10-29","filed_date":"2020-11-12","scope":"insider"},{"id":9204758,"accession":"0000899243-20-025618","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-025618","line_url":"/filing/0000899243-20-025618#line-4","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":null,"owner_name":"Chart Westcott Living Trust; Ikarian Capital, LLC; Ikarian Healthcare Fund GP, L.P.; Ikarian Healthcare Master Fund, L.P.; Shahrestani Neil","owner_display_name":"Chart Westcott Living Trust","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":78201.0,"shares_display":"78,201","price_per_share":3.926,"price_display":"3.93","price_state":"stated","total_value":307017.126,"total_display":"307,017.13","total_whole":"307,017","shares_owned_after":2162549.0,"shares_owned_after_display":"2,162,549","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-11","filed_date":"2020-09-17","scope":"insider"},{"id":9204756,"accession":"0000899243-20-025618","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-025618","line_url":"/filing/0000899243-20-025618#line-3","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":null,"owner_name":"Chart Westcott Living Trust; Ikarian Capital, LLC; Ikarian Healthcare Fund GP, L.P.; Ikarian Healthcare Master Fund, L.P.; Shahrestani Neil","owner_display_name":"Chart Westcott Living Trust","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":79415.0,"shares_display":"79,415","price_per_share":3.4938,"price_display":"3.49","price_state":"stated","total_value":277460.127,"total_display":"277,460.13","total_whole":"277,460","shares_owned_after":2084348.0,"shares_owned_after_display":"2,084,348","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-09","filed_date":"2020-09-17","scope":"insider"},{"id":9204759,"accession":"0000899243-20-025618","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-025618","line_url":"/filing/0000899243-20-025618#line-2","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":null,"owner_name":"Chart Westcott Living Trust; Ikarian Capital, LLC; Ikarian Healthcare Fund GP, L.P.; Ikarian Healthcare Master Fund, L.P.; Shahrestani Neil","owner_display_name":"Chart Westcott Living Trust","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":13244.0,"shares_display":"13,244","price_per_share":2.9,"price_display":"2.90","price_state":"stated","total_value":38407.6,"total_display":"38,407.60","total_whole":"38,408","shares_owned_after":2004933.0,"shares_owned_after_display":"2,004,933","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-08","filed_date":"2020-09-17","scope":"insider"},{"id":9204757,"accession":"0000899243-20-025618","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-025618","line_url":"/filing/0000899243-20-025618#line-1","is_derivative":false,"issuer_cik":"0001394319","issuer_name":"Tracon Pharmaceuticals, Inc.","issuer_ticker":"TCON","issuer_name_source":null,"issuer_url":"/issuer/0001394319","owner_cik":null,"owner_name":"Chart Westcott Living Trust; Ikarian Capital, LLC; Ikarian Healthcare Fund GP, L.P.; Ikarian Healthcare Master Fund, L.P.; Shahrestani Neil","owner_display_name":"Chart Westcott Living Trust","owner_url":null,"role":"Ten percent owner, Other","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, par value $0.001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":151611.0,"shares_display":"151,611","price_per_share":2.8659,"price_display":"2.87","price_state":"stated","total_value":434501.9649,"total_display":"434,501.96","total_whole":"434,502","shares_owned_after":1991689.0,"shares_owned_after_display":"1,991,689","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-09-04","filed_date":"2020-09-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001394319","name":"Tracon Pharmaceuticals, Inc.","url":"/issuer/0001394319","role":"Ten percent owner, Other","n_filings":3,"first_seen":"2020-09-17","last_seen":"2020-12-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001825313","retrieved_at":"2026-08-22T07:33:13+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}